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The purpose of this study was to investigate the association between Chlamydia 
trachomatis reinfection rates of Puerto Rican adolescents and failure to follow the 
retesting protocol, failure of sexual partners to receive treatment, and failure to participate 
in the sexual orientation program about risk factors. Secondary data analysis, from a 
historical prospective study from the Health Department of Puerto Rico, was used in this 
study. Data analysis was restricted to adolescents 15 to 19-years-old who had a positive 
chlamydia result and reinfection pattern since January 2008 through December 2012. 
Multiple logistic regression analyses were run to predict Chlamydia trachomatis 
reinfection. Results showed a statistically significant association association between 
Chlamydia trachomatis reinfection and not having followed the retesting protocol 
(OR=1.243, 95% CI 1.089-2.930, p-value 0.038). A statistically significant association 
association was found between Chlamydia trachomatis reinfection and sexual partners 
having not received treatment (OR=1.713, 95% CI 0.761-2.024, p-value 0.029). A 
statistically significant association was found between Chlamydia trachomatis reinfection 
and having not participated in the Puerto Rico Department of Health’s sexual orientation 
program (OR=1.243, 95% CI 0.762-2.026, p-value 0.034).  
The contribution to social change is identifying factors significantly associated with 
Chlamydia trachomatis reinfection. Study findings provide useful guidance for clinicians 
and public health professionals on how to reduce Chlamydia trachomatis reinfection rates 
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Chapter 1: Introduction to the Study  
Sexually transmitted diseases (STDs) are a group of transmissible diseases that 
are acquired by sexual contact. Chlamydia trachomatis is the most common sexually 
transmitted bacterium producing over 3 million new cases yearly in United States and 
Europe (Oakeshott et al., 2010). Infections produced by chlamydia remain asymptomatic 
and may go undiagnosed and untreated. The infection in women can result in pelvic 
inflammatory disease, causing infertility, severe pelvic pain and ectopic pregnancy. 
Chlamydia is responsible for up to 55% of the chronic urethritis in men. Individuals aged 
20- to 24-years-old have the highest rates of chlamydia infection, followed by 
adolescents aged 15 to 19 (Center for Disease Control and Prevention [CDC], 2008). In 
Puerto Rico in 2008, the age-adjusted rate for females 15 to 19 was 1,219.0 and the rate 
for males was 96.5. However, in 2009, the total number of chlamydia cases increased in 
Puerto Rico, with an age adjusted rate of 1,277.5 in females 15 to 19 and 124.8 for males. 
In 2010, chlamydia age-adjusted rates were as follows: in females 15 to 19, 1,059.0 and 
for males were 146.1. In 2011, chlamydia age-adjusted rates were the following: females 
15 to 19, 1,027 and for males were 132.5. In 2012, the total number of chlamydia cases 
increased, with an age-adjusted rate of 1,048.7 in females 15 to 19 and 575.2 for males 
(Department of Health of Puerto Rico, 2013). 
The World Health Organization (WHO; 2005) indicated that sexually active youth 
aged 10-20 years constitute a critical period due to the transition to emotional and 
maturity to sexual behaviors. Sexually active young adolescents ages 15 to 19 and young 




United States and territories. According to DiClemente, Salazar, and Crosby (2007), left 
untreated, STD infections may produce serious complications including cervical cancer, 
infertility, or death.  
Table 1 shows that the group with the highest incidence of chlamydia trachomatis 
is the group ages 20 -24, followed by the group of adolescents ages 15-19. The following 
table shows age-adjusted rate, gender, and incidence per 100,000 habitants of the same 
age and gender in years since 2008 through 2012 in Puerto Rico.  
Table 1 
Chlamydia Trachomatis. Adjusted Rate per Age and Gender in Puerto Rico, 2008-2012 
Group 
2008 2009 2010 2011 2012 
Age adjusted rate Age adjusted rate Age adjusted rate Age adjusted rate Age adjusted rate 
Male Female Male Female Male Female Male Female Male Female 
10-14 2.6 49.4 3.9 51.7 0.8 34.5 0.7 34.3 1.5 25.1 
15-19 96.5 1,219.0 133.8 1,396.5 146.1 1,059.0 132.5 1,027.2 119.4 1,048.7 
20-24 225.3 1,585.2 293.2 1,074.3 311.5 1,491.1 337.7 1,441.6 346.9 1,651.9 
25-29 119.2 745.1 169.9 829.1 174.5 543.6 209.1 583.7 212.5 656.9 
30-34 33.9 304.2 48.2 309.5 81.3 189.7 85.2 195.4 98.6 228.1 
35-39 14.6 129.5 22.8 112.6 42.5 66.4 55.2 85.4 44.0 109.3 
40-44 14.0 51.6 12.3 45.4 14.4 28.9 21.8 35.3 23.5 29.1 
45-54 6.1 20.3 11.1 26.6 11.5 13.2 11.1 9.6 14.6 17.2 
55-64 2.0 9.3 3.6 3.8 4.9 3.3 4.0 5.0 4.4 6.7 
65+ 0.4 1.7 0.9 3.1 3.0 2.3 0.8 0.7 2.5 2.3 
Note. Source: Department of Health of Puerto Rico (2013). 
Chlamydia trachomatis infection is treated on site. A single dose of 
Azythromycin 1g is given to those positive cases. To control disease transmission and/or 
reinfection, patients treated for chlamydia should avoid sexual intercourse for at least 7 
days after the initial prophylaxis. To control the risk of reinfection, sexual partners are 





Chlamydia trachomatis is the most common sexually transmitted bacteria 
(Gottlieb et al., 2010). Repeated infections and coinfections have been found to be 
common after treatment. The main reasons for reinfection include failure of sexual 
partners to receive treatment and unprotected sexual intercourse with new sexual partners 
(Heijne, Althaus, Herzog, Kretzschmar, & Low, 2010). Coinfections with other STDs are 
a concern (Marangoni et al., 2012). According to the CDC (2010c), the most common 
coinfections in United States and Puerto Rico include gonorrhea, syphilis, human 
papilloma virus (venereal warts), and HIV. In Puerto Rico, chlamydial reinfection and 
coinfection have increased in the age group of 15-19, (CDC, 2010c). Even when 
gonorrhea has declined, chlamydia coinfection with gonorrhea has a high prevalence 
among infected people (14.5%; CDC, 2010c).  
Chlamydia coinfects with HIV (CDC, 2010c). According to Joyee, Thyagarajan, 
Reddy, Venkatesan, and Ganapathy (2005), HIV coinfection with chlamydia is high and 
requires a routine screening for chlamydia and interventions to reduce the spreading of 
STDs. Chlamydia infection is mainly asymptomatic and under diagnosed, contributing to 
the spread of other STDs. Chlamydia infection facilitates the susceptibility, acquisition, 
and transmission of other STDs up to five fold (Nusbaum, Wallace, Slatt, & Kondrad, 
2004). Sexually transmitted infections have shown to influence the transmission of HIV 
since STIs inhibit the lactic acid produced by Lactobacillus, predominant bacterium 
found in vaginal secretions. The inhibition of the lactic acid may enhance the 




STD costs are increasing in Puerto Rico yearly (Department of Health of Puerto 
Rico, 2013). Chlamydia trachomatis is the most common bacterium that is sexually 
transmitted. Based on the high incidence of chlamydia, the Department of Health of 
Puerto Rico considered testing and treating chlamydia infection for wedding purposes.  
Law no. 133 of 1937, which was changed, established that all persons getting married 
must undergo the Treponema pallidum, or syphilis test, in order to obtain a wedding 
license (LexJuris of Puerto Rico, 2007).  
A chlamydia reinfection pattern has been observed when a sexual partner failed to 
receive treatment (CDC, 2010c). As stated by the STD treatment guidelines from the 
Health Department of Puerto Rico (2006, 2010) and CDC (2006a, 2010c), a follow-up 
treatment is recommended to test all recently infected patients. Women and men should 
visit the STDs clinics after 1 month after initial treatment for retest. It is also 
recommended that patients receive a follow up after 3 months, even when sexual partners 
have not received treatment. 
Problem Statement 
Chlamydia trachomatis is a bacterium that causes genital infections. It produces 
cervicitis and urethritis in women and produces urethritis in men (Trelle, Shang, Nartey, 
Cassell, & Low, 2007). Virulent strains are found to cause rectal and pharyngeal 
infections; these strains are transmitted during labor and can cause pneumonia and eye 
infections in infants. Strains L1, L2, and L3 cause lymphogranuloma venereum, a severe 
inguinal infection that primarily infects the lymphatic nodes (Blank, Schillinger, & 




to 30% of the patients infected develop inguinal lymphadenopathy, which can progress to 
a severe inguinal obstruction causing elephantiasis (Ginige, Fairley, Hocking, Bowden, & 
Chen, 2007).  
About 30% of untreated cervical chlamydiosis resulted in pelvic inflammatory 
disease within a few weeks of infection. Approximately 20 to 25 % of those women with 
pelvic inflammatory disease that become pregnant will have an ectopic pregnancy or 
become infertile (Molano et al., 2005). About 50% of chlamydia infections resolve 
spontaneously without treatment. However, reinfections occur easily, particularly when 
sexual partners refuse to be treated (Simms, Warburton, & Westrom, 2003).  
According to the Department of Health of Puerto Rico (2010), Chlamydia 
trachomatis is the most common STD found in adolescents ages 15 to 19. Chlamydia 
diagnoses occur more frequently in women because they visit physicians more frequently 
than men. During gynecological visits, women are screened routinely to detect STDs to 
reduce the risk of complications (Ginige et al., 2007).  
Reinfection patterns among Puerto Rican adolescents are very limited. There is a 
lack of statistical analysis and information in Puerto Rico regarding the risk factors 
associated with reinfection in this population. I investigated the risk factors associated 
with chlamydia reinfection among Puerto Rican adolescents using secondary data 
analysis from 2008 through 2012. 
Nature of the Study 
I conducted a secondary analysis of existing data within the 2008-2012 




Department of Puerto Rico. The target population included adolescents aged 15 to 19 
years old who tested positive for Chlamydia trachomatis during the years of 2008 
through 2012. The purpose of this study was to investigate the association between 
Chlamydia trachomatis reinfection and failure to receive antibiotic therapy, failure of 
sexual partners to receive treatment and to follow the retesting protocol, and failure to 
participate in the program offered by the Health Department of sexual orientation about 
risk factors during chlamydia treatment. Data access included if the patient received 
antibiotic therapy and participated in the retesting protocol, if there was documentation of 
notification and treatment of sexual partners, if the patient participated in the sexual 
orientation program about risk factors offered by the Health Department; and patient risk 
history with two or more sex partners during chlamydia treatment, if the patient had new 
sex partners during chlamydia treatment, and the patient used a condom. The 
methodology and research design will be discussed in Chapter 3 of this study. 
Research Questions and Hypotheses 
Research Question 1. Is the high rate of Chlamydia trachomatis reinfection 
outcomes in Puerto Rican adolescents associated with failure to receive antibiotic 
therapy and to follow the retesting protocol established by the health department? 
H10: There will not be a significant association between Chlamydia trachomatis 
reinfection and failure to receive antibiotic therapy and to follow the retesting protocol 




H1A: There will be a significant association between Chlamydia trachomatis 
reinfection and failure to receive antibiotic therapy and to follow the retesting protocol 
established by the health department. 
Research Question 2. Is Chlamydia trachomatis reinfection outcome in Puerto 
Rican adolescents associated with gaps in notification and screening sexual 
partners for infection? 
H20: There will not be a significant association between Chlamydia trachomatis 
reinfection and failure of sexual partners to receive treatment.  
H2A: There will be a significant association between Chlamydia trachomatis 
reinfection and failure of sexual partners to receive treatment. 
Research Question 3. Is Chlamydia trachomatis reinfection in Puerto Rican 
adolescents associated with participation in the program of sexual orientation 
about risk factors offered by the health department during chlamydia treatment? 
H30: There will not be a significant association between reinfection with 
participation in the program of sexual orientation about risk factors offered by the health 
department during chlamydia treatment. 
H3A: There will not be a significant association between reinfection with 
participation in the program of sexual orientation about risk factors offered by the health 
department during chlamydia treatment. 
Purpose 
 The purpose of this study was to conduct a secondary data analysis to evaluate 




15 to 19 years. Predictors to study were postperiodic and follow-up treatment, 
notification and screening of sexual partners, and participation in the sexual education 
program about risk factors offered by the health department.  
Epidemiological Conceptual Model 
Historically, adolescents have some common antecedents prior to having multiple 
sexual partners or outcomes that are associated with a sexual risk behavior. High risk 
behaviors include a lack of parental monitoring, community factors, school orientation, 
poverty, socioeconomic level, impulsivity, perception of the risk of infection, and self-
esteem (DiClemente et al., 2007).  
If Chlamydia trachomatis is left untreated, it may cause pelvic inflammatory 
disease, which may result in infertility, severe pelvic pain, and ectopic pregnancy. 
Chlamydia also enhances the susceptibility of coinfections including gonorrhea, 
trichomonas vaginalis, genital warts, and HIV (Molano et al., 2005; Novak & Karlsson, 
2006). Chlamydia exposure increases the probability of HIV infection (Joyee et al., 
2005). According to Advocates for Youth (2008), Puerto Rico had the top 10 highest 
incidence of HIV cases in 2004. However, the infection often remains asymptomatic; 
hence, it is often undiagnosed and untreated. The highest incidence of chlamydia is 
reported in young adolescents ages 15 to 19 (DiClemente et al., 2007).  
According to the CDC (2012), only 38% of 60,000 men and women who had a 
positive chlamydia screening between 2007 and 2009 participated in an Infertility and 
Prevention Project in New York, New Jersey, and the U.S. Virgin Islands. They were 




spreading of chlamydia and other STDs. In order to reduce Chlamydia trachomatis 
infections, it is necessary to screen sexual partners and improve antibiotic treatment to 
reduce reinfections (Batteiger et al., 2010). The goal of this study was to reduce 
Chlamydia trachomatis reinfection and associated adverse sequellae.  
Definitions 
 Adolescents: A person aged 15 to 19 years of age who is physiologically 
immature that reflects psychological and intellectual immaturity (US Department of 
Health and Human Services, 2007).  
 Azithromycin: An antibiotic that is used to treat bacterial infections that can cause 
throat infections, skin infections, urethral, cervical, or genital ulcers and middle ear 
infections (Physician Desk Reference [PDR], 2010).   
Behavioral change: A modification strategy that seeks to extinguish or inhibit an 
undesirable behavior to a desired behavior (DiClemente et al., 2007).  
Chlamydia: A common bacterium capable of producing genital infections. The 
infection may result in chronic urethritis, epididymitis, cervicitis, and acute salpingitis. 
(CDC, 2010c). 
Coinfection: When an infection is produced by two or more pathogens 
simultaneously, a coinfection is produced. The most common coinfection with 
Chlamydia trachomatis is frequently found among patients who have gonococcal 




Follow up treatment and retesting program: The CDC recommended follow up 
after 3 to 4 weeks, 3 months, and 12 months after completing therapy to evaluate if the 
person is cured, for new symptoms, and if reinfection is suspected (CDC, 2010c). 
Genital herpes: Condition caused by Herpes Simplex Virus that produces a 
painful genital lesion (CDC, 2006a). 
Genital warts: An infection produced by Human Papilloma Virus in the external 
genitalia or perianal region. The disease is associated with the development of cancer 
(CDC, 2006b). 
Gonorrhea: A sexually transmitted bacterium capable of producing urethritis, 
epididymitis, or salpingitis (CDC, 2006b). 
Initially infected: The first infection developed by any STD, which is transmitted 
by sexual contact (CDC, 2010c). 
Notification and screening sexual partners: The CDC recommended referring 
sexual partners for evaluation and treatment if infection is suspected. Antibiotic therapy 
can be delivered with the patient as chlamydia reinfection is associated with failure in 
sexual partners’ notification (CDC, 2010c). 
Prevention program: An approach used to anticipate social, physical, and 
environmental precautions to avoid side effects (DiClemente et al., 2007).  
Sexual education: The process of training about sexual discipline that requires 
knowledge skills, education, and character about the sexual components (US Department 




 Reinfection: Reinfection occurs when, after treatment, an infection repeats. 
Chlamydia trachomatis reinfection occurs because untreated sexual partners may have 
different sexual partnerships (CDC, 2010c). 
Sexually transmitted diseases (STDs): A group of diseases that spread by having 
intimate sexual intercourse with someone who has the disease (US Department of Health 
and Human Services, 2007). 
Syphilis: A complex infection caused by the bacteria Treponema pallidum. The 
infection has three stages (primary, secondary, and tertiary). Most of the time, primary 
and secondary syphilis are asymptomatic. Clinical problems occur in the tertiary stage 
where the central nervous system results impacted with neurosyphilis (CDC, 2006c). 
Assumptions 
Researchers have been reviewing Chlamydia trachomatis reinfection based on 
behavioral intervention programs and notification and treatment of sexual partners 
(Batteiger et al., 2010; Hwang, Tebb, Shafer, & Plantell, 2005). Assumptions of this 
research include the following: 
 Chlamydia is the most common sexually transmitted infection found in the 
United States, its territories, and Europe (Oakeshott et al., 2010). 
 This bacterium may produce serious complications including infertility, 
ectopic pregnancy, cervical cancer, or death (Molano et al., 2005). 
 Adolescents are the most exposed group to Chlamydia trachomatis in the 
United States. Familiar environment, parental monitoring, community, 




important to educate adolescents and to help them to develop behavioral 
modifications toward sexuality (DiClemente et al., 2007). 
 Chlamydia trachomatis reinfection in adolescents mostly occurs because, 
even when they receive appropriate therapy, their sexual partners do not 
receive treatment (Batteiger et al., 2010; Hwang et al., 2005).  
Limitations 
This research was limited existing data that were gathered from the STD MIS 
software program of the Health Department of Puerto Rico. I collected data from 
adolescents aged 15-19 who tested positive to Chlamydia trachomatis between January 
2008 and December 2012. Patterns of reinfection, antibiotic therapy, notification, and 
treatment of sexual partners, screening for reinfections, and participation in the program 
of sexual education about risk factors offered by the Health Department were considered 
for the purpose of this study. 
Delimitations 
Data provided were exclusively from adolescents who visited the public health 
clinics of the Health Department of Puerto Rico. Data did not contain information about 
private physicians or any other treatment. 
Significance of the Study 
The CDC (2010c) recommended that patients need to be instructed to contact 
their sexual partners in order to receive evaluation, counseling, testing, and treatment for 




is important to receive a follow-up antibiotic treatment with counseling about STDs to 
avoid recurrence (CDC, 2010c). 
Implications for Social Change 
Researchers have been designing programs to achieve significant sexual 
behavioral change. Interventions have targeted individuals for positive attitudes toward 
abstinence, condom use, and self efficacy to motivate adolescents to seek behavioral 
change. According to Robin et al. (2004), interventions have achieved significant sexual 
behavior and outcome. Pedlow and Carey (2003) demonstrated that unprotected sex can 
be reduced up to 75%, condom use can improve up to 53%, and sustained new preventive 
behavioral methods can be achieved.  
This study may lead to positive social change by is identifying the necessity to 
reduce Chlamydia trachomatis transmission based on follow-up treatment of sexual 
partners and counseling about sexual behavior to prevent reinfection, morbidity, and 
mortality associated with other STDs. 
Summary 
Chlamydia trachomatis is the most common sexually transmitted bacteria 
(Gottlieb et al., 2010). Repeated infections and coinfections have been found to be 
common after treatment. The purpose of this study was to conduct a secondary data 
analysis to evaluate risk factors associated with chlamydia reinfection among Puerto 
Rican adolescents aged 15 to 19 years. I conducted a secondary analysis of existing data 




Chapter 2 of this research include the literature on Chlamydia trachomatis 
reinfection patterns, notification and treatment of sexual partners, behavioral 
interventions, and risk reduction program need in order to reduce Chlamydia trachomatis 
infections among Puerto Rican adolescents. Chapter 3 is an explanation of the methods 
used to gather and interpret the data. Chapter 4 is a report of the data and Chapter 5 is the 




Chapter 2: Literature Review 
Introduction 
Chlamydia trachomatis is an obligate intracellular bacterium that produces genital 
tract infections in women and men. It is the most common STI reported in the world 
(Gottlieb et al., 2010). Chlamydia is reaching epidemic rates because most of the time it 
is asymptomatic and humans are reluctant to address sexual behavioral issues and 
outcomes (Gottlieb et al., 2010). All communities are impacted by chlamydia and all 
individuals are impacted for the costs associated by this disease (Weinstock, Berman, & 
Cates, 2004). The annual treating includes chlamydia infections and PID produced by it, 
which reaches $10 billion. C. trachomatis has become a public health problem that needs 
attention and a genuine solution because over 3 million people are infected in the United 
States each year (Weinstock et al., 2004).  
C. trachomatis is the most common sexually bacterial infection in the world 
(Gottlieb et al., 2010). It is capable of infecting the genital organs of women and men. 
Generally, the infection does not produce symptoms or can produce mild symptoms 
(Trelle et al., 2007). As a silent condition it can produce serious and irreversible 
complications. Chlamydia has become a public health problem since many cases cannot 
be reported because most of the people do not know they are infected with chlamydia. It 
is estimated that 2 million people in the United States and territories are infected without 
symptoms (Oakeshott et al., 2010). Reinfection occurs easily if the partners do not 
receive treatment (DiClemente et al., 2007). Chlamydia prevalence and incidence is 




This chapter is a review of literature related to C. trachomatis incidence, clinical 
consequences, economic evaluation, and the benefit of a risk reduction program. The 
literature review is based on argued presentations published in peer reviewed journals 
about chlamydia, risk reduction programs, and behavioral interventions. Primary source 
information was performed using EBSCO database, Medline, Medscape and Pub Med, 
and summary publications produced by such authoritative sources as the World Health 
Organization, the USPHS’s CDC, and the Department of Health of Puerto Rico.  
Natural History of Chlamydia trachomatis 
 C. trachomatis is an obligate intracellular pathogen, living only inside human 
cells (Carlson et al., 2008). C. trachomatis is a gram negative bacterium that includes 
three human serotypes (A, B, C) producing trachoma (eye infection), serotypes (D-K) 
producing urethritis, and serotypes (L1, L2 and L3) producing lymphogranuloma 
venereum (Carlson et al., 2008). Chlamydia presents intracytoplasmic inclusions within 
the human cell that infect the host nucleus (Carlson et al., 2008). This bacterium was first 
isolated from embryonated eggs in 1957. In this isolation it was confirmed that chlamydia 
is not able to synthesize its own ATP (Trentmann, Horn, van Scheltinga, & Haferkamp, 
2007). Chlamydia requires the human cell for reproduction and virulence. The 






Figure 1. The developmental cycle of Chlamydia trachomatis. Reprinted by permission 
from Macmillan Publishers Ltd: Nature Reviews Immunology, 5, 149-161, copyright 
2005, Source from Brunham & Ladino.  
 
C. trachomatis is an obligate intracellular pathogen, infecting only humans, 
contains two stages for developmental life cycle. The first stage is the infectious 
elementary body (EB) that attaches and enters the human epithelial cells through the 
membrane (Brunham & Ladino, 2005). After entering the human cell, the EB produces a 
vacuole that helps it to create the habitat for the replication. Then after 12 hours the EB is 
transformed into an active reticulate body (RB) which starts reproduction by binary 




into 100 to 1,000 EB, which are released from the vacuole capable to infect other cells 
(Brunham & Ladino, 2005).  
Symptoms may vary; 75% of women and 25% of men do not present symptoms at 
all. In women, symptoms are presenting with an increased vaginal discharge with burning 
sensation during urination, irritability in the vaginal area, may produce bleeding after 
sexual intercourse, and abdominal pain (Novak & Karlsson, 2006). Most of the time, the 
infection starts at the cervix area. In men, the infection starts as a non gonococcal 
urethritis, which is the main symptom (Novak & Karlsson, 2006). This includes a 
yellowish discharge, burning sensation during urination and pain (Novak & Karlsson, 
2006).  
Another infection produced by C. trachomatis is lymphogranuloma venereum, 
characterized by swelling of the lymph nodes. This disease produced proctitis in men and 
rectal narrowing in women (Molano et al., 2005). During its primary stage small ulcers 
are detected in the groin area. In the secondary stage, ulcers start a suppurative 
lymphadenopathy, named a bubo that produces fever and generalized arthralgia. During 
the tertiary stage, rectal complications occur (Molano et al., 2005).  
The majority of the STD cases worldwide are caused by C. trachomatis producing 
a public health problem concern (Rekart & Brunham, 2008). Commonly, it produces an 
asymptomatic infection in men and women. Men serve as a carrier of the bacteria even 
with asymptomatic infection, spreading the infection to other persons. Women have a 
higher probability to develop severe complications after infection. In an acute infection 




term consequences such as salpingitis, chronic pain, infertility, and ectopic pregnancy 
(Novak & Karlsson, 2006).  
According to Morrison and Morrison (2005), even when antibiotics are effective 
against chlamydia, the definite control to eradicate this disease can be achieved with 
vaccination. The understanding of the human’s immune response remains unclear. 
Chlamydia muridarum produces genital infections to mice which is very similar to the 
infection produced by C. trachomatis in humans (Morrison & Morrison, 2005). The 
immune response in mice followed by C. muridarum infection has been studied. 
Depletion of CD4
+
 T cells antibodies in mice produces an infection that do not resolve. 
The mechanisms to develop protection against chlamydia will vary among host and cell 
mediated immunity (Morrison & Morrison, 2005). The antibody response is not well 
understood. It is known that the chlamydial elementary body is blocked in the presence of 
the antibody. Depletion of the antibodies may facilitate reactivation of the elementary 
body, and hence triggering infection (Morrison & Morrison, 2005).   
Conjunctival infections can occur during labor from mothers to babies. The 
inflammation of the eyelid or trachoma is one of the most common infections causing 
blindness worldwide (Mariotti, Pascolini, & Rose-Nussbaumer, 2009). Over 140 million 
persons have conjuctival infection and 6 million are blind in regions such as Africa, Asia, 
and Latin America (Mariotti et al., 2009). The disease is prevalent in rural populations 
with limited personal hygiene and water. Trachoma is considered a communicable 




The transmission of C. trachomatis occurs trough infected secretion during sexual 
contact. Chlamydia penetrates areas such as cervix, urethra, rectum, throat and 
conjunctiva of the eyes (Novak & Karlsson, 2006). After spreading via sexual contact it 
manifests a disease (Novak & Karlsson, 2006).  
Chlamydia trachomatis infection enhances other STDs colonization (Joyee et al. 
2005). Serological tests for IgG antibodies against chlamydia are more likely found in 
those with Neiserria gonorrhea and HIV infected patients (Joyee et al., 2005; Vonck, 
Darville, O’Connell, & Jerse, 2011). Significantly more gonococci have been found in 
laboratory mice coinfected with chlamydia than those with gonorrhea alone. Chlamydia 
has been observed to induce alterations in the host’s response enhancing the possibility of 
coinfection with other STDs (Vonck et al., 2011). Coinfection was not to be considered 
for the purpose of this study. 
Chlamydia has shown to resolve without treatment. Factors of spontaneous cure 
are under study that should clarify a feasibility of a vaccine against chlamydia (Parks, 
Dixon, Richey, & Hook, 1997). Samples of untreated patients have been evaluated to 
detect those whose first culture is positive and without treatment the repeated cultures 
were negative. A retrospective study was performed with data derived from patients 
attending an STD Clinic in Birmingham, Alabama. Samples were taken prior a positive 
test for gonorrhea and a history of chlamydia infection. Chlamydia cultures of 325 
patients presented positive growth between June 1992 and January 1996. Patients who 
received treatment were excluded from the study. There were 311 medical records 




culture samples were retaken and cultures were repeated. The study population was five 
men and 69 women. The cultures revealed that 34 out of 74 patients resulted with a 
negative follow up culture (P=0.05, RR= 1.458, 95% CI 0.911-2.333). Those with 
persistent infections were treated with antibiotic (Parks et al., 1997). Age correlated with 
the clearance proportion. Those patients 30 years of age and older had the highest 
proportion of spontaneous clearance, seven out of 15. However, 16 patients were 15 to 19 
years of age. Only three out of 16 of the younger population resulted negative in the test. 
Older patients may have developed a host response because they could have had the 
infection before and the immune system developed a memory against the infection.  
Clinical Consequences 
Cervicitis 
 The narrow neck of the uterus is named cervix and it is usually the initial site of 
the common STDs. The inflammation of the cervix is known as cervicitis, which is a 
common sequelae produced by C. trachomatis (Marrazzo & Martin, 2007). 
Mucopurulent cervicitis (MPC) is characterized by a visible purulent exudate. MPC is 
mainly asymptomatic but may produce endocervical bleeding. The condition may persist 
as a chronic cervicitis producing endometrial infection or may infect the uterus, fallopian 
tubes and ovaries producing PID (Marrazzo & Martin, 2007).  
Pelvic Inflammatory Disease 
 PID is a clinical syndrome characterized by an infection and chronic 
inflammation of the uterus, fallopian tubes and ovaries or woman’s pelvic organs. The 




Stephens, 2007). During the inflammatory process chemokine interleukin 8 (IL-8) is 
produced by the cells infected with chlamydia. IL-8 is necessary to activate neutrophils 
that in the presence of host’s cells, chlamydia infection produces damaging to the 
surrounding tissues (uterus, fallopian tubes, ovaries, and pelvic organs). Consequently, 
chronic inflammation occurs, however the exact pathway stills unknown (Buchholz & 
Stephens, 2007).  
Women infected with C. trachomatis have the possibility to develop PID more 
than any other bacteria (Oakeshott et al., 2010). The common signs are lower abdominal 
pain, irregular menstruation, fever, and chronic pelvic pain. Twelve percent of women 
will become infertile after the first episode of PID. Over 50% of women with a second 
episode of PID will become infertile. The highest incidence of PID is found among 
sexually active adolescent women between ages 15 to 19 years. Within this group, one 
out of eight women infected with Chlamydia develop PID, in contrast one out of 80 
women 25 years of age or older develop PID. According to Oakeshott et al., women over 
25 year are more likely to visit their physician to receive treatment than adolescents 15 to 
19 years of age. This is the main reason of PID rate. 
 Each year, 200,000 women develop infertility as a consequence to chlamydia 
infection in the United States (Oakeshott et al., 2010). Positive associations have been 
observed in women with C. trachomatis and cervical premalignancies that could have 
been caused by an increased susceptibility to acquire Human Papilloma virus infections 
(Safaeian et al., 2010). According to Oakeshott et al. (2010), hospitalization is 




and is not responding to oral medication. It is recommended testing all sexually active 
women for chlamydial infections, particularly those women who have multiple sex 
partners and all that are pregnant (Oakeshott et al., 2010).  
Virulence Factors 
C. trachomatis starts the colonization to the host’s cells using the sialic acid 
receptors for attachment on the eye, throat or genital organs (Carlson et al., 2008). After 
penetrating to the body, human antibodies, T cells and B cells cannot recognize it. 
Chlamydia contains a unique gram negative cell wall that contains the outer 
lipopolysaccharide membrane, but lacks peptidoglycan layer. The lack of this layer does 
not permit antibodies to attach it, since this layer usually contains muramic acid which is 
the target of antibodies. Instead of muramic acid, the cell wall contains cysteine rich 
proteins that allow chlamydia to survive outside the host’s cell (Brunham & Ladino, 
2005).  
The identification of a possible vaccine against chlamydia has been conducted 
(Swanson et al., 2009). According to Tan et al. (2010), all chlamydia species contain a 
polymorphic membrane protein D (PmpD) that suppresses host immunity. The 
mechanism of this protein is under study to produce a vaccine that could neutralize 
PmpD, conferring immunity to the host (Swanson et al., 2009). Azythromycin has 
become the drug of choice to treat chlamydia. One single dose is enough to treat and cure 






A cross sectional study was conducted with prisoners attending a family clinic in 
a Swiss prison (Steiner et al., 2010). Participants were 18 to 35 years old. Questionnaires 
were completed about sociodemographic factors, used of IV drugs, health habits, 
antibiotic treatment within the past 3 months, and urogenital symptoms. There were 214 
men and 20 women that participated in the study. Among the participants were Africans 
(49.5%), Europeans (31.5%), Asians (15.3%) and Americans (3.6%). 35.7% had a lower 
level of education. Urine samples were analyzed for chlamydia detection using PCR 
technique. Infection was found in 14 out of 214 males (6.5%, 95% CI 3.2–9.9) and in 2 
out of 20 females (10%; 95% CI 0–23.1). The relationship of chlamydia infections and 
participants were as follows: 8.7 of the infected were under 25 years old, while 5.3 were 
higher 25 years old; 10% were women, 6.5% were men; 9.5% were symptomatic 
(presented uro-genital complications), while 3.9% were asymptomatic; 7.6% had 2 or 
more sexual partners in the last year, 6.4% had 1 sexual partner. Chlamydia was found to 
be higher in those below 25 years of age.  
Corbeto et al. (2010) conducted a study in the province of Barcelona in 2007 
regarding the prevalence of C. trachomatis infections and showed incidence rates 
significantly greater in those young women less than 25 years of age. Corbeto et al. used 
a sample of 397 adolescents and young women among 16 to 35 years. Findings revealed 
that C. trachomatis had an incident rate significantly higher in those under 25 years of 




origin (OR 4.7, 95% CI 1.02-21.8); had a sexual partner in the last three months (OR 4.59 
CI 1.16–18.08); and smoking tobacco in the last 12 months (OR 6.38 CI 1.16–34.93) 
(Corbeto et al., 2010). The study showed a higher trend of chlamydia infections in young 
women, which was consistent with the findings reported in the rest of Europe. 
Klavs, Rodrigues, Welling, Kese, and Hayes (2004) conducted a study in 
Slovenia of the general population 18 to 49 years old to evaluate the prevalence of 
Chlamydia trachomatis. The objective of this national survey was to identify 
demographic factors and behavior to those infected with chlamydia. The study was 
conducted in different Slovenian health centers. Data collection starts in November 1999 
ending February 2001. Questionnaires were administered to 849 men and 903 women 
ages 18 to 49. The number of participants the responded the survey were 683 and 764 
women. Urine samples were used for testing C. trachomatis. Klavs et al. excluded those 
individuals who had never had sexual intercourse. The groups were distributed as 
follows: 18-24, 25-34, and 35-49. The prevalence among the population 18-24 was the 
highest (men and women 4.1%; CI 2.2 to 7.4), followed by the group 25-34 (men 3.6%; 
CI 1.6 to 4.9), (women 2.0%; CI 0.7 to 5.1), and then the group 35-49 resulted with lower 
risk (men 2.1%; CI 0.9 to 4.9), (women 0.3%; CI 0.0 to 2.0). Klavs et al. concluded that 
the prevalence of Chlamydia is higher in the population 18 to 24 years old. 
Coinfection  
Coinfection occurs when a simultaneous infection is produced by two or more 
pathogens. Under coinfection interactions, C. trachomatis is capable to enhance its 




have been associated particularly with Neiserria gonorrhea and Trichomonas vaginalis 
(Barbosa et al., 2010; Khan et al., 2005). Coinfection was not be considered for the 
purpose of this study. 
A cross sectional study was performed in six STI clinics in Brazil in 2005 to 
assess the prevalence of C. trachomatis and Neiserria gonorrhea coinfection (Barbosa et 
al., 2010). The clinics were part of the Brazilian Public Health Care, which are free 
public clinics maintained by government. Patients had no costs for medical visits, 
laboratory tests or treatment. The study required to enroll 750 participants to provide 80% 
power to estimate the prevalence of C. trachomatis (Barbosa et al., 2010). Informed 
consent from parents was obtained for those under 18 years old. A total of 767 men 
participated in this study. The mean age was 26.5 years, with a standard deviation of 8.3 
years. (SD 8.3). HIV positive men were excluded from the study. The prevalence of 
chlamydia infection was 13.1% (95% CI 10.7%-15.5%), while gonorrhea was 18.4% 
(95% CI 15.7%-21.1%). Coinfection was 4.4% (95% CI 2.95%-5.85%). Demographic 
patterns and STD prevalence showed that 52.4% were men 15 to 24 years old; 59.8% of 
those infected were unmarried and 73.5% had an income below the Brazilian minimum 
wage. The factors identified to present coinfection were participants among 15-24 years 
old, presented urethral discharge, and have had genital warts. The main risk factors were 
found as multiple sexual partners and inadequate condom use. The screening showed that 
coinfection with gonorrhea is more likely in younger people (below 25 years old; 




Between April 2000 and October 2003, Khan et al. (2005) studied sexually active 
males and females who visited a STI clinic in Indianapolis, IN. Participants were 
heterosexual between the ages of 15 to 25 years of age. The objective was the study was 
to estimate the rate of Chlamydia, Neiserria gonorrhea and Trichomonas vaginalis 
coinfections (Khan et al., 2005). The number of participants was 210, 101 males and 109 
females. The results were as follow, 46% had Chlamydia, 18% had N. gonorrhea and 
14% had Trichomonas vaginalis. The partners of 72 subjects infected with chlamydia 
were contacted and tested for the same bacteria. Partners’ results were as follow, 57% 
had Chlamydia and N. gonorrhea co-infection, and 20% had Trichomonas vaginalis. 
Participants and partners received treatment. The study discusses that there are substantial 
numbers of Chlamydia-N. gonorrhea coinfections that can be associated with other STIs, 
such as Trichomonas vaginalis. Khan et al. concluded that patient-delivered partner 
therapy (PDPT) is an effective strategy to decrease the risk of reinfection in patients, 
since most of the time sexual dyad members share the same infections.  
Sexual Partners 
Treatment of sexual partners has proved to be an effective strategy in preventing 
and reducing coinfections and STI sequelae (Khan et al., 2005). Many infected partners 
do not receive treatment. Partner notification is the way the health care provider ensure 
the proper treatment for persons implicated. When there is more than one partner the 
notification occurs at low rates producing difficulties to seek health care attention (Khan 
et al., 2005). Commonly, sexual partners share the same STIs than index subject. There 




(Khan et al., 2005). The patient-delivered partner therapy (PDPT) is an effective strategy 
to decrease the risk of reinfection.  
The English National Chlamydia Screening Program, in UK, performed a cost 
effectiveness treatment for those sexual partners of subjects diagnosed with C. 
trachomatis. The study was conducted in 2008-2009, of notification and screening of 
sexual partners. The model showed that notification and proper treatment will reduce the 
cost per infection over six times (Turner et al., 2011). The notification and treatment is 
likely to cost less than if partners never receive proper attention. The probability of 
reinfection after counseling and treatment was also reduced dramatically, and long term 
complications associated with chlamydia. The study was limited to chlamydia infections 
only. 
Socioeconomic Status 
Chlamydia infections have been associated with socioeconomic status (Radcliffe, 
Ahmad, Gilleran, & Ross, 2001). A case-control study was performed from June 1997 to 
June 1998 in the Whittall Street Clinic in Birmingham. This clinic is part of the National 
Health Service and a free STI clinic in UK. Participants completed a questionnaire about 
age, sex, marital status, ethnic group, occupation, income, number of partners, use of 
condom, tobacco, alcohol and drug habits and previous diagnosis of chlamydia and N. 
gonorrhea. A power analysis suggested a sample size of 1124 participants for a power of 
80% with a confidence level of 95%. The study recruited 1371 participants (526 cases 
and 845 controls). All participants were tested for chlamydia and N. gonorrhea using 




N. gonorrhea. Controls were those free of both infections. Characteristics and 
demographic factors of those with chlamydia showed, 149 (24%) never use condom; 415 
(67%) sometimes use condom; 88 (12%) had a previous history of gonorrhea; 115 (17%) 
had a previous history of chlamydia; 289 (30%) were smokers; 302 (31%) consumed 
alcohol; 91% of infected participants were unmarried; 279 (28%) were under 24 years 
old; 130 (20%) were unemployed; 143 (23%) were students; 42 (7%) were homemakers 
and 318 (50%) had low salary income. Chlamydia infections were associated with 
decreased condom use, being single, low income and age less than 24 years (Radcliffe et 
al., 2001).  
Chlamydia Reinfections 
C. trachomatis reinfections are very common among middle and high school 
students (Gaydos et al., 2008). In a school based study performed between 1996-2003, 
10,609 high school students females were tested for the presence of chlamydia. 
Reinfection was considered when positive results occur between 30 to 365 days after the 
initial positive result. The first test was at 30 days, and then a second test was in 3 
months, a third test was in 9 months, and last test in 1 year. There were 897 females that 
resulted positive, and were retested within 1 year. From these there were 236 that resulted 
with reinfection after 1 year follow up. Gaydos et al. presented that in 1996 there were 
512 females tested, from that 82 (CI 12.8-19.2) were positive for chlamydia, within 1 
year 13 (CI 12.9-36.1) had reinfection. At the end of the study in 2003, there were 1922 




27(CI 14.4-28.8) were reinfected. The incidence of reinfection since 1996 to 2003 was 
26.3% (95% CI 23.4-29.2%) within 1 year.  
Chlamydia reinfections occur because untreated partners may have different 
sexual partnerships (Heijne et al., 2010). Reinfection after treatment is very common due 
to failure to screen partners, or subsequent partners have asymptomatic infection. A 
chlamydia infection process model was developed following the model of Kretzschmar 
and Dietz (1998). The model was used to predict the re-infection process. C. trachomatis 
transmission occurs if there is a susceptible host, and only one infected partner is 
necessary to transmit the disease. The majority of individuals with asymptomatic 
infection will never know about the infection. Only 30% of the asymptomatic infections 
could be detected if they are partners of a symptomatic or under treatment person. 
Continuous reinfection will occur since the disease is mainly asymptomatic and no 
notification for treatment is received.  
Intervention Effectiveness 
Condom use and Behavioral Interventions 
A study to promote behavioral intervention to promote condom use was 
conducted in Ciudad Juarez, and Tijuana Mexico between January 2004 to January 2006 
(Patterson et al., 2008). Patterson et al. recruited 924 female workers. The eligibility 
requirements were being older than 18 years, having traded sex for money or drugs 
within the previous 2 months of the study, and no condom use. Baseline and behavioral 
interventions were conducted. Baseline and follow up included working with self-esteem, 




Behavioral interventions were conducted in two groups, Mujer Segura Intervention 
(Healthy Woman), and didactic control group. Motivational techniques were used such as 
to protect one’s own health, to avoid STIs, to feel clean, safer sex with clients, and 
engagement of protection. The didactic control group was exposed to a weekly computer 
program providing information about HIV and STI. Blood tests were collected to conduct 
syphilis and HIV tests. Chlamydia and gonorrhea tests were conducted from vaginal 
swabs. At baseline, 55 out of 924 resulted with HIV, and 869 were negative; 132 had 
syphilis, 25 had gonorrhea, and 48 had chlamydia. Participants received treatment. After 
6 months follow up, the incidence of HIV was 0 out of 869 originally seronegative; 6 had 
syphilis; 9 had gonorrhea and 13 had chlamydia. Patterson et al. showed that behavioral 
interventions integrating a change of behavior can significantly reduce unprotected sex, 
HIV and STI incidence. Interventions addressed the social and cultural conditions to 
identify barriers and solutions to set the adequate counseling.  
A Transtheoretical Model of Change (TTM) has been used as a framework for 
behavioral interventions such as protective behaviors, condom use and STI prevention 
(Chacko et al., 2010). The TTM promotes that individuals adopt and maintain a positive 
behavior. A randomized controlled clinical trial was conducted in an urban clinic in 
Texas, from May 2002-February 2003. Participants were women, English speakers, not 
pregnant, single, HIV negative, who did not use alcohol or drugs. The number of eligible 
participants was 950. Behavioral interventions were conducted at baseline, 2 weeks, 6 
months, and 12 months. Interventions were oriented to condom use, the importance of 




chlamydia and gonorrhea decreased after 12 months follow up, and the condom use 
increased from 7% at baseline to 13% at the end of the study (Chacko et al., 2010).  
Mass Treatment of at Risk Population 
Oral Azithromycin has been used to treat communities to control the spreading of 
C. trachomatis infections from mothers to babies. During labor, mothers infect their 
babies causing trachoma to the eyes, which is the leading cause of blindness worldwide 
(Porco et al., 2009). Mass treatment in Tanzania was conducted in children and their 
parents (Cajas et al., 2011). Treatment was given to all families who live distance of 
source of water and had presence of one or more flies on the face. Swabs of the eyelid 
were collected before treatment. Single dose of Azithromycin 20 mg was given to all 
children 6 months and older in four villages. There were 1,991children treated at 
baseline. From that 1,412 were negative for the test and treated at baseline; 81 were not 
treated at baseline and not infected; 445 were infected and treated and 18 were infected 
but not treated. According to Cajas et al. (2011), mass antibiotic treatment as a goal to 
control chlamydia infection, and recommended treating every 6 months families and 
children in places where trachoma is a concern.  
Treatment 
C. trachomatis is a treatable disease that requires treating all sex partners of those 
who have resulted positive for chlamydia. According to Porco et al., (2009), 
Azithromycin 1 gram orally in a single dose is the drug of choice because it has been 
demonstrated a cure rate of 98% of the cases. Azithromycin is especially the best drug 




follow up treatment it is recommended to retest the patients after 3 to 4 weeks of 
completing the therapy to evaluate if the person is cured. The majority of the post 
treatment infections occur because sex partners have failed to be treated and have no 
notification for treatment (Porco et al., 2009). 
Critique of Methods 
Methodologies of studies presented in this proposal mention reinfection and 
coinfection risk factors associated with age, notification and treatment of sexual partners, 
socioeconomic status, condom use and behavioral interventions and mass treatment. 
Cross sectional studies presented on this chapter demonstrated health related aspects, 
sociodemographic characteristics, gender and age as potential risk factors for the 
prevalence of Chlamydia trachomatis among certain groups of people (Corbeto et al., 
2010; Klavs et al., 2004; Steiner et al., 2010). However, no researcher mentioned the 
impact of behavioral interventions and/or counseling.  
Patient-delivered partner therapy has showed to be an effective strategy to 
decrease the risk of chlamydia reinfection (Turner et al., 2011). According to 
Kretzschmar and Dietz (1998), an infection process is the key to predict the reinfection in 
susceptible hosts, and only one infected partner is necessary to transmit the disease. 
Continuous re-infection will occur if partners’ notification and treatment are not 
accomplished. These researchers did not present counseling as part of the partners’ 
therapy. Behavioral interventions such as the Trans theoretical Model of Change 




can decreased dramatically the rate of reinfection within the period of follow up 
treatment.  
Prevention 
Chlamydia is a preventable disease that requires different strategies to be 
controlled (DiClemente et al., 2007). Low prevalence of consistent condom use, not 
giving treatment to sexual partners, and multiple sexual encounters can increase the risk 
of chlamydia acquisition. So the basis of the prevention counseling is to minimize sexual 
risk behavior through modifying the risk factors in order to have lower rates of 
reinfection.  
Experiments with animal models and limited human studies have suggested that 
the response against C. trachomatis could be mediated by a strong interferon (IFN). This 
response may neutralize C. trachomatis activity. A model for a vaccine has been 
proposed by Gray, Beagley, Timms, & Wilson (2009). There is evidence that the 
experimental vaccine could induce partial immunization against C. trachomatis.  
DiClemente et al. (2007) presented a public health concern and have tried to 
prepare risk reduction programs and targeting to workers, schools and community 
programs. According to Lee, Jung, Kwon, Jung, and Park (2010), chlamydia is 
preventable if there are resources for protection programs. These authors performed a 
cross sectional study in Korea for condom use among females in 2004. After the study, 
women revealed to be more conscious toward self-protection, prevalence, and 





Chlamydia infections have been shown to be the most common STI in the United 
States, and are most of the time asymptomatic (Gottlieb et al., 2010). The infection can 
produce serious complications such as salpingitis, PID and coinfections with gonorrhea, 
Trichomonas vaginalis, and genital warts. The literature reviewed show that chlamydia is 
a preventable disease that can be controlled with notification and treatment of sexual 
partners, screening for reinfections and participation in a program for sexual education. 
Low prevalence of C. trachomatis is strongly related with behavioral modifications, 
responsibility, and consistent condoms use (Lee et al., 2010). A knowledge gap is 
associated with its high prevalence, reinfection rate and morbidity. It is important to 
emphasize that the highest incidence occurs in young people 15 to 20 years of age. 





Chapter 3: Research Method 
Introduction 
Chlamydia trachomatis is the most common STI reported worldwide (Gottlieb et 
al., 2010; Oakeshott et al., 2010). It is an obligate intracellular bacterium that produces 
genital tract infections in both women and men. Untreated it causes pelvic inflammatory 
disease, which may result in infertility, severe pelvic pain, and ectopic pregnancy, also 
enhances the susceptibility of coinfections with gonorrhea, Trichomonas vaginalis, 
genital warts, and HIV (Molano et al., 2005; Novak & Karlsson, 2006). Chlamydia 
exposure increases the probability of HIV infection (Joyee et al., 2005). According to 
Advocates for Youth (2008), Puerto Rico resulted within the top 10 highest incidence of 
HIV cases in 2004. However, the infection often remains asymptomatic and thus 
undiagnosed and untreated. Highest incidence is reported in young adolescents ages 15 to 
19 (DiClemente et al., 2007).  
CDC (2010) guidelines for STD Treatment established the following medical care 
for Chlamydia:  
Repeat infections confer an elevated risk for PID and other complications. Unlike 
the test-of-cure, which is not recommended, repeat C. trachomatis testing of 
recently infected women or men should be a priority for providers. Chlamydia-
infected women and men should be retested approximately 3 months after 
treatment, regardless of whether they believe that their sex partners were treated. 
If retesting at 3 months is not possible, clinicians should retest whenever persons 




According to The Department of Health of Puerto Rico (2012), the majority of 
people infected with chlamydia receive appropriate antibiotic therapy. The Health 
Department takes care of detection of other STDs, and retests them for reinfections. 
However, prevention counseling for STDs reoccurrence is mainly voluntarily. During 
routine visits and/or exams, adolescents decide if they will participate in safer sex 
counseling and orientation. Reinfections patterns could be link with a knowledge gap. 
Chlamydia trachomatis and STDs should be not only additional testing, but proper 
counseling and support is needed. 
To address the proper counseling and knowledge gaps, a secondary data analysis 
from a historical-prospective study was proposed to explore the management of Puerto 
Rican adolescents (15 to 19 years old) following a chlamydia infection, which includes 
antibiotic treatment, partners’ notification, reinfection and safer sex counseling and 
orientation.   
Research Questions 
Research Question 1 
Is the high rate of Chlamydia trachomatis reinfection outcomes in Puerto Rican 
adolescents associated with failure to receive antibiotic therapy and to follow the 
retesting protocol established by the Health Department? 
Reinfection occurs when after initial treatment the same infection occurs again. 
Reinfection is common after treatment. For that reason, the CDC (2010c) recommended 




completing therapy to evaluate if the person is cured, for new symptoms and if 
reinfection and/or coinfection are suspected (CDC, 2010c). 
In this study, a multiple logistic regression model was used as quantitative method 
to associate reinfection with failure to receive antibiotic therapy and to follow the 
retesting protocol established by the Health Department. Reinfection was measured as 
dependent variables and failure to receive antibiotic therapy and to follow the retesting 
protocol were measured as independent variables. 
Research Question 2 
Is Chlamydia trachomatis reinfection outcome in Puerto Rican adolescents 
associated with gaps in notification and screening sexual partners for infection? 
The CDC (2010c) recommended referring sexual partners for evaluation and 
treatment if infection is suspected. Antibiotic therapy can be delivered with patient itself 
as chlamydia reinfection is associated with failure of sexual partners to receive treatment 
(CDC, 2010c). In this study a multiple logistic regression model was used to associate 
reinfection patterns with gaps in notification and screening sexual partners. Reinfection 
was measured as dependent variable and gaps in notification and screening sexual 
partners were measured as independent variables. 
Research Question 3 
Is Chlamydia trachomatis reinfection in Puerto Rican adolescents associated with 
participation in the sexual orientation program about risk factors offered by the Health 




The CDC (2010c) recommended that patients need to receive counseling, testing 
and treatment for any STD. A behavioral change has been presented as a public health 
solution to reduce the risk factors associated with STDs (DiClemente et al., 2007). In this 
study a multiple logistic regression model was used to measure the association of 
reinfection patterns with the participation in the sexual orientation program about risk 
factors. Reinfection was measured as dependent variables and the participation in the 
sexual orientation program about risk factors was measured as independent variable. 
Patients’ risk factors evaluated were the following: patient risk history with two or more 
sex partners during chlamydia treatment, new sex partners during chlamydia treatment, 
and condom use. 




Figure 2. Diagram showing Chlamydia trachomatis reinfection patterns. 
 Retesting protocol, participation in the orientation program and 
notification and treatment of partners means independent variable. 
 Reinfection means dependent variable or outcome.  
 Follow up period means after 3 to 4 weeks after initial treatment, at 3 




















































1. The study consisted in evaluating secondary data from the Health 
Department of Puerto Rico of adolescents 15 to 19 years old who had a 
positive Chlamydia trachomatis laboratory result. According to the 
Sexually Transmitted Disease Treatment Guidelines from the CDC 
(2010), after receiving treatment for Chlamydia trachomatis infection 
patients should be tested after 3 to 4 weeks, 3 months and 12 months in 
order to evaluate if the infection was resolved.  
2. Antibiotic therapy and follow up after 3 to 4 weeks, 3 months and 12 
months were considered. 
3. Notification and treatment of sexual partners were evaluated.  
 CDC guidelines and The Health Department of Puerto Rico recommend 
treating sexual partners to reduce the adverse outcomes of post 
transmission. 
4. Participation in the sexual orientation program about risk factors and STD 
prevention was evaluated to establish if those who did not participate were 
at higher risk of reinfection. During the sexual orientation program, it is 
discussed if the patient has had two or more sex partners during chlamydia 
treatment, new sex partners during chlamydia treatment, and condom use. 
Low prevalence of consistent condom use and multiple sexual partners can 






The Health Department of Puerto Rico has 10 public health clinics around the 
Island for STDs tests and prevention services. Testing, screening, and treatment protocols 
are followed based on the STD Treatment Guidelines from the CDC (2010). Patients’ 
data are filled out in a questionnaire by the public health personnel about race, ethnicity, 
physical address, age (including minors), and reason for visit/test, type of health care 
provider, laboratory test type, patient risk history, contacts or partners, and clinical 
findings. As part of the STDs screening of the Public Health Clinics, patients provide 
samples for testing. For Chlamydia trachomatis screening patients must provide urine 
samples collected into a sterile container. Urine samples are analyzed in the clinical 
laboratory of the Health Department by authorized personnel. Patients are screened with 
or without symptoms as routine test or follow up after treatment.  
Multiple STD tests on the same person are able to be linked under a unique record 
number. Patients with any positive Chlamydia trachomatis result test start its 
correspondent’s treatment. A single dose of Azythromycin 1g is given as treatment for 
Chlamydia trachomatis. Patient interview is necessary to evaluate the risk factors 
associated with STDs; they are also advised to refer their partners to the Health 
Department for proper treatment. Patients are then cited for follow up treatment after 3 to 
4 weeks, eventually at third month follow up, and after 12 months in order to evaluate if 
there is a sustained negative result in those patients under antibiotics treatment. 
Eventually, all data are collected into a STD MIS official software program under the 




between Chlamydia trachomatis reinfection among sexually active adolescents 15 to 19 
years old.  
Participants 
The study was based on existing data since January 2008 through December 
2012, from adolescents 15 to 19 years old, collected under the STD MIS software 
program of the Health Department of Puerto Rico. I had the intention to measure the 
follow up treatment and safer sex counseling and orientation based on CDC guidelines. 
Electronic documentation provided by the Health Department was evaluated: screening 
of reinfections, antibiotic therapy, notification and treatment of sexual partners, and 
participation in the sexual orientation program about risk factors offered by the Health 
Department. Risk factors discussed in the sexual orientation program are, two or more 
sex partners during chlamydia treatment; new sex partners during chlamydia treatment; 
and condom use. 
Sample Population 
I intended to examine all Chlamydia trachomatis positive cases identified by the 
Health Department of Puerto Rico between January 2008 and December 2012. Measures 
of association between risk factors (IVs) and outcomes (DVs) were determined using a 
tabulation of those adolescents reinfected and those initially infected from a historical 
prospective study in Puerto Rico since 2008-2012. There were a total of 9,022 Chlamydia 
trachomatis cases in the ages 15-19 years old since 2008-2012. The entire population was 




The STD MIS official software program under the Health Department of Puerto 
Rico provided the positive Chlamydia trachomatis cases in adolescents 15 to 19 years old 
that were tested in the public health clinics of the Health Department of Puerto Rico. This 
information was limited to unique client number identifier, age, sex, date of initial 
positive chlamydia test, treatment date, follow up treatment, result of follow up, history 
of re-infection, sexual partners’ notification and treatment and participation in the sexual 
orientation program about risk factors, number of sexual partners during chlamydia 
treatment, and condom use. This was the population analyzed for this study purposes.  
Specimen Collection 
Data for the study already exist based on samples collected by the Public Health 
Department of Puerto Rico. Specimens’ collection for Chlamydia trachomatis was 
following the STD Treatment Guidelines from the CDC (2006a, 2010c). Urine samples 
were taken by each patient and placed into a sterile container and sent to the laboratory, 
Samples were sent to the public health clinics laboratory where authorized personnel 
tested the samples for the corresponding analysis. Each sterile container was labeled with 
patient’s name, date of collection and specimen’s source.  
Laboratory Testing 
The nucleic acid amplification technique (NAATs) was used to analyze and detect 
the presence of Chlamydia trachomatis in the samples submitted by the patients. The 
method is also used to detect N. gonorrhea. The assay is used to detect chlamydia in both 
symptomatic and asymptomatic individuals. The test is performed to endocervical 




characteristic of NAATs is that is designed to amplify the nucleic acid of the organism. 
Historically, cell culture has been considered as the gold standard for chlamydia 
detection. Since there have been discrepancies between laboratories, cell culture has been 
replaced by NAAT.  
Aptima Combo 2 predictive values for positive and negative results were 
calculated based on hypothetical prevalence. The sensitivity and specificity for 
Chlamydia trachomatis are 96.1% specificity and 98.0% sensitivity. NAATs produce 
positive signal when a single copy of ribosomal RNA (rRNA) is found in the sample. 
Specific region for Chlamydia trachomatis is found in 23S rRNA (Gen-Probe, 2012).  
Data Collection 
Public Health Clinics in Puerto Rico receive many patients for Sexually 
Transmitted Diseases analysis. Some STD patients may be diagnosed and treated by 
private clinicians and eventually called and interviewed by the Public Health Clinic 
personnel. Partners are advised by the patient who resulted with a positive test to visit the 
public health clinics to receive treatment. Participation and education of partners for safer 
sex is mainly voluntary. Interviews, analysis, and proper treatment are given to those 
partners who visit the clinics. There is no evidence whether or whether not a lack of 
educational counseling could be linked with reinfections patterns among Puerto Rican 
adolescents.  
A data use agreement form authorized by the Walden’s Institutional Review 
Board (IRB) was used as an agreement with the Health Department of Puerto Rico to 




requested was, patient antibiotic therapy, follow up retesting protocol, history of 
chlamydia reinfection, documentation of notification and treatment of sexual partners, 
participation in the sexual education program about risk factors, history of two or more 
sex partners during chlamydia treatment, new sex partners during chlamydia treatment, 
and condom use. All information provided by this program is under a unique record 
number for each participant. The unique record number is retained for each patient so 
records can be linked. There is no name under this program. Reinfection is considered 
after 30 days of initial treatment.  
Data Analysis 
Data analysis was restricted to adolescents 15 to 19 years old who had C. 
trachomatis infection and reinfection patterns since January 2008 through December 
2012. STD MIS software used in the Puerto Rico Health Department was used using the 
record number of each Chlamydia trachomatis positive cases since 2008 through 2012 
from the adolescents’ population 15 to 19 years old. Once the population was selected 
reinfection with chlamydia was investigated using the same record number.  
STD MIS System provided the following information for the purpose of this 
study: 
1. Unique participant record number to ensure unduplicated record. 
2. Participant age and gender at the time of initial chlamydia positive result. 
3. Date of initial chlamydia positive result. 
4. Date of follow up treatment. 




6. Condom use after positive chlamydia test result. 
7. Number of partners during treatment. 
8. Documentation of notification and treatment of sexual partners. 
9. Documentation of orientation of the sexual program about risk factors 
offered by the Health Department during chlamydia treatment. 
The epidemiology model proposed was based on a multiple logistic regression to 
establish the association of reinfection those adolescents. This model provided a rationale 
of the odds of and occurring outcome as (DVs). Adjusted odd ratio (OR) was used to 
present the probability of the occurring event in those adolescents reinfected and those 
initially infected. STD MIS software contains demographic information of each 
participant of the public health clinics under a unique record number. The same number 
was used for routinely visits. There is no participants’ name under this system; there is no 
personal intervention with participants in this research. All information gathered was 
used for this research purpose only.  
Summary 
The purpose of this study was to conduct a secondary data analysis to evaluate 
risk factors associated with C. trachomatis reinfection among Puerto Rican adolescents 
aged 15 to 19 years. Predictors to study were postperiodic and follow-up treatment, 
notification and screening of sexual partners, and participation in the sexual orientation 






Chapter 4: Results  
Introduction 
The purpose of this study was to investigate the association between Chlamydia 
trachomatis reinfection and failure to receive antibiotic therapy and to follow the 
retesting protocol, failure of sexual partners to receive treatment, and failure to participate 
in the sexual orientation program about risk factors. I used secondary data to enable 
historical prospective study in cooperation with the Health Department of Puerto Rico. 
Data analysis was restricted to adolescents 15 to 19 years old who had a positive C. 
trachomatis result and reinfection pattern during the period January 2008 through 
December 2012.  
Research Questions and Hypotheses 
Research Question 1 
Is the high rate of Chlamydia trachomatis reinfection outcomes in Puerto Rican 
adolescents associated with failure to receive antibiotic therapy and to follow the 
retesting protocol established by the health department? 
H10: There will not be a significant association between Chlamydia trachomatis 
reinfection and failure to receive antibiotic therapy and to follow the retesting protocol 
established by the health department. 
H1A: There will be a significant association between Chlamydia trachomatis 
reinfection and failure to receive antibiotic therapy and to follow the retesting protocol 




The results showed that there is a significant association between Chlamydia 
trachomatis reinfection and failure to follow the retesting protocol established by the 
Health Department. The statistical result had the OR=1.243, 95% CI 1.089-2.930. The 
information provides evidence to reject the null hypothesis. 
Research Question 2 
Is Chlamydia trachomatis reinfection outcome in Puerto Rican adolescents 
associated with gaps in notification and screening sexual partners for infection? 
H20: There will not be a significant association between Chlamydia trachomatis 
reinfection and failure of sexual partners to receive treatment.  
H2A: There will be a significant association between Chlamydia trachomatis 
reinfection and failure of sexual partners to receive treatment. 
The result showed that reinfection is more likely to occur when sexual partners do 
not receive treatment. Analysis revealed that the OR=1.713, 95% CI 0.761-2.024. The 
information provides evidence to reject the null hypothesis. 
Research Question 3 
Is Chlamydia trachomatis reinfection in Puerto Rican adolescents associated with 
participation in the program of sexual orientation about risk factors offered by the 
health department during chlamydia treatment? 
H30: There will not be a significant association between reinfection with 
participation in the program of sexual orientation about risk factors offered by the health 




H3A: There will not be a significant association between reinfection with 
participation in the program of sexual orientation about risk factors offered by the health 
department during chlamydia treatment. 
The results showed an association between reinfection and no participation in the 
sexual orientation program. Analysis revealed that the OR=1.243, 95% CI .762-2.026. 
The information provides evidence to reject the null hypothesis. 
Data Collection 
Walden University’s IRB approved this research, IRB Approval Number 03-24-
14-0106581. After the approval, data collection started. For the purpose of this study, 
STD MIS data were downloaded and transported to the statistical program SPSS 22.0.  
Descriptive Statistics 
Data provided by the Puerto Rico Department of Health consisted of those 
positive Chlamydia trachomatis cases in adolescents 15 to 19 years and reinfection 
during the period January 2008 through December 2012. The demographic information 
was limited to age and gender. The clinical information was limited to positive chlamydia 
result, those who attended the Department of Health to be retested (follow up treatment), 
chlamydia reinfection, sexual partners’ notification, and participation in the sexual 
orientation program about risk factors. There were a total of 9,022 Chlamydia 
trachomatis cases in the ages 15-19 years old since 2008-2012. The entire population was 




Information used were from adolescents whose initial Chlamydia trachomatis 
occurred within the study period. Table 2 presents the demographic information of the 
study population. 
Table 2  
Demographic Information of the Study Population 15-19 Years old From 2008-2012 
Gender 
Infected Reinfected 
N % N % 
Male 1,279 14.2 72 0.8 
Female 7,743 85.8 238 2.6 
Total 9,022    100 310 1.7 
             Infected Reinfected 
Age Male % Female % Male % Female % 
15 61 0.7 486 6.3 0 0.0 0 0.0 
16 111 1.2 1,001 12.9 2 0.0 4 0.0 
17 279 3.1 1,426 18.4 12 0.1 22 0.2 
18 362 4.0 2,281 29.5 22 0.2 63 0.7 
19 466 5.2 2,549 32.9 36 0.4 149 1.7 
Source: Department of Health of Puerto Rico (2013). 
The population analyzed was 9,022 adolescents infected for first time with 
Chlamydia trachomatis, ages 15 to 19 years old from 2008-2012. The population initially 
infected was 1,279 males (14.2%) and 7,743 females (85.8%). The population reinfected 





Table 3 presents the descriptions of the follow up treatment, sexual partners’ 
treatment, and participation in the sexual orientation program. 
Table 3  




   




% Based on 
N=9,022 






Initially infected that followed the retesting protocol   -  
  Male 736 8.2  13.9 
  Female 4,549 50.4  86.1 
  Total 5,285 58.6  100.0 
Initially infected that did not follow the retesting 
protocol 
  -  
  Male 471 5.3  13.8 
  Female 2,956 32.8  86.2 
  Total 3,427 38.1  100.0 
Reinfected that followed the retesting protocol     
  Male 13 0.1 4.2 12.2 
  Female 94 1.0 30.3 87.8 
  Total 107 1.1 34.5 100.0 
Reinfected that did not follow the retesting protocol    - 
  Male 59 0.6 19.0 29.0 
  Female 144 1.6 46.5 71.0 
  Total 203 2.2 65.5 100.0 
Initially infected whose sexual partners received 
treatment 
  -  
  Male 698 7.7  12.8 
  Female 4,573 50.7  87.2 
  Total 5,271 58.4  100.0 
Initially infected whose sexual partners did not 
receive treatment 
  -  
  Male 571 6.3  16.6 
  Female 2,870 31.8  83.4 
  Total 3,441 38.1  100.0 




  Male 10 0.1 3.2 7.9 
  Female 116 1.3 37.5 92.1 
  Total 126 1.4 40.7 100.0 
Reinfected whose sexual partners did not receive 
treatment 
    
  Male 62 0.7 20.0 33.7 
  Female 122 1.4 39.3 66.3 
  Total 184 2.1 59.3 100.0 
Initially infected that participated in the sexual 
orientation program 
  -  
  Male 648 7.2  12.8 
  Female 4,423 49.0  87.2 
  Total 5,071 56.2  100.0 
Initially infected that did not participate in the 
sexual orientation program 
  -  
  Male 566 6.2  15.4 
  Female 3,075 34.1  84.6 
  Total 3,641 40.3  100.0 
Reinfected that participated in the sexual orientation 
program 
    
  Male 9 0.1 2.9 8.6 
  Female 96 1.1 31.0 91.4 
  Total 105 1.2 33.9 100.0 
Reinfected that did not participate in the sexual 
orientation program 
    
  Male 56 0.6 18.1 27.3 
  Female 149 1.7 48.0 72.7 
  Total 205 2.3 66.1 100.0 




The number of initially infected attending the Department of Health and that were 
retested (follow up treatment) resulting with a negative Chlamydia trachomatis result was 
736 males (13.9%) and 4,549 females (86.1%). The number of initially infected whose 
sexual partners received treatment were 698 males (12.8%) and 4,573 females (87.2%). 
Initially infected that participated in the sexual orientation program were 648 males 
(12.8%) and 4,423 females (87.2%).  
The number of reinfected that followed the retesting protocol was 13 males 
(12.2%) and 94 females (87.8%). Reinfected whose sexual partners received treatment 
were 10 males (7.9%) and 116 females (92.1%). Reinfected that participated in the sexual 
orientation program were 9 males (8.6%) and 96 females (91.4%). 
I used the statistical program SPSS 22.0 to analyze the data in Multiple Logistic 
Regression Model to measure the relationship between the dependent variable 
(reinfection) and the following independent variables.  
 Failure to follow the retesting protocol established by the Health 
Department.  
 Gaps in notification and screening sexual partners. 
 Failure to participate in the sexual orientation program about risk factors. 
 The association between age and gender and chlamydia reinfection. 
Multiple Logistic Regression 
 To determine the association between three independent variables in this study to 
predict Chlamydia trachomatis reinfection, multiple logistic regression was analyzed. 




protocol and the outcome. There is a statistically significant difference between initially 
infected adolescents that attended the Department of Health to be retested for chlamydia 
reinfection (follow up treatment) and those reinfected who did not follow the retesting 
protocol. Those who did not follow the retesting protocol are more likely to have a 
reinfection (OR=1.243, 95% CI 1.089-2.930, p-value 0.038). However, there are no 
statistically significant differences between females and males (OR=0.992, 95% CI 
0.561-1.756, p-value 0.979). There are no statistically significant differences between age 
group 16-17 and age group 18-19 (OR=1.943, 95% CI 0.877-4.303, p-value 0.102). 
With regard to sexual partners’ treatment, the logistic regression showed that there 
is a statistically significant association in those reinfected adolescents whose sexual 
partners did not receive treatment (OR=1.713, 95% CI 0.761-2.024, p-value 0.029). No 
statistically significant differences were found in age (OR=0.845, 95% CI 0.569-1.768, p-
value 0.544) or gender, (OR=1.943, 95% CI 0.318-1.242, p-value 0.182). 
Regarding the participation in the sexual orientation program, there is a 
statistically significant association in those adolescents that did not participate in the 
sexual orientation program (OR=1.243, 95% CI 0.762-2.026, p-value 0.034). Age or 
gender does not show statistically significant differences. Age 18-19 has OR=1.087, 95% 
CI 0.526-2.249, p-value 0.822; and females have OR=1.003 CI 0.569-1.768, p-value 
0.992. 
With regard reinfection based on age and gender, there is a statistically significant 
association between reinfected females with reinfection (OR=1.976, 95% CI 1.605-2.334, 




reinfected age group 18-19 and reinfection (OR=1.911, 95% CI 1.556-2.266, p-value 
0.006). 
Table 4 summarizes the Multiple Logistic Regression results.  
Table 4 
Multiple Logistic Regression to Predict Factors Associated With Chlamydia Reinfection 
Among Adolescents 15-19 Years old from 2008-2012 
Characteristics B S.E. Wald Sig. Exp(B) 95.0% CI for Exp (B) 
Reinfected that attended the  
Department of Health                                                                           
to be retested for 
chlamydia reinfection 
(follow up treatment)       
Yes (Reference)       
No 0.217 0.249 0.758 0.038* 1.243 1.089-2.930 
       
Gender       
Male (Reference)       
Female -0.008 0.291 0.001 0.979 0.992 0.561-1.756 
       
Age       
16-17 (Reference)       
18-19 0.664 0.406 2.680 0.102 1.943 0.877-4.303 
       
Reinfected whose Sexual Partners received 
treatment       
Yes (Reference)       
No 0.538 0.246 4.796 0.029* 1.713 0.761-2.024 
       
Gender       
Male (Reference)       
Female -0.168 0.277 0.369 0.544 0.845 0.569-1.768 
       
Age       
16-17 (Reference)       
18-19 -0.464 0.348 1.785 0.182 0.628 0.318-1.242 
       
Participation in the sexual orientation 
program       
Yes (Reference)       
No 0.217 0.249 0.758 0.034* 1.243 0.762-2.026 
       
Gender       
Male (Reference)       
Female 0.003 0.289 0.000 0.992 1.003 0.569-1.768 




Age       
16-17 (Reference)       
18-19 0.084 0.371 0.051 0.822 1.087 0.526-2.249 
       
       
Reinfection based on gender       
Male (Reference)       
Female 0.683 0.364 3.687 0.009* 1.976 1.605-2.334 
       
Reinfection based on age       
16-17 (Reference)       
18-19 0.648 0.355 3.688 0.006* 1.911 1.556-2.266 
a
B is the coefficient for the constant                                         
b
Exp(B) is the exponentiation of the B coefficient, or the Odds Ratio 
Sig is the p-value  
*Results in bold are statistically significant (p-value <0.05) 
Summary 
There is a significant difference between initially infected adolescents that 
followed the retesting protocol versus reinfected adolescents that did not follow the 
retesting protocol. The results showed an association between reinfection with failure to 
follow the retesting protocol established by the Health Department. There is an 
association between reinfection and failure of sexual partners’ treatment and there is an 
association between reinfection and no participation in the sexual orientation program 
offered by the Health Department. There is also an association between females and 
reinfection and ages 18-19 and reinfection. Recommendations and social implications are 




Chapter 5: Summary, Recommendations, and Conclusions 
Summary 
The purpose of this study was to examine the association between Chlamydia 
trachomatis reinfection and failure to receive antibiotic therapy and to follow the 
retesting protocol, failure of sexual partners to receive treatment, and failure to participate 
in the sexual orientation program about risk factors. I used secondary data from a 
historical prospective study from the Puerto Rico Department of Health. There were 
9,022 adolescents 15 to 19 years old who had a positive chlamydia result since January 
2008 through December 2012. Reinfection was analyzed in these adolescents. 
The findings of the data analysis showed that there were significant differences 
between reinfected and initially infected adolescents. Alternative Hypothesis 1 
established that there would be a significant association between Chlamydia trachomatis 
reinfection and failure to follow the retesting protocol established by the Department of 
Health. This hypothesis was accepted. Alternative Hypothesis 2 established that there 
would be a significant association between Chlamydia trachomatis reinfection and failure 
of sexual partners to receive treatment. This hypothesis was accepted. Alternative 
Hypothesis 3 established that there would be a significant association between reinfection 
and participation in the sexual orientation program about risk factors offered by the 
Department of Health during chlamydia treatment. This hypothesis was accepted. This 
chapter is a discussion of the hypotheses, the social implications of chlamydia infections 





Interpretation of the Findings 
Research Question 1 
The results of this study demonstrated that there was a statistically significant 
association in those reinfected adolescents that did not follow the retesting protocol of the 
Department of Health. The logistic regression model presented that reinfected 
adolescents analysis showed OR=1.243, 95% CI 1.089-2.930, and p-value 0.038. Thus, 
this hypothesis was accepted. Age (p-value 0.102) or gender (p-value 0.979) does not 
show stastically significant differences. 
There were 736 males (13.9%) and 4,549 females (86.1%) that follow the 
retesting protocol. There were 471 males (13.8%) and 2,956 females (86.2%) initially 
infected that did not follow the retesting protocol. Reinfected that follow the retesting 
protocol were 13 males (12.2%) and 94 females (87.8%). Reinfected that did not follow 
the retesting protocol were 59 males (29.0%) and 144 females (71.0%). This finding is 
consistent with other researchers who stated that reinfections are common among middle 
and high school students (Gaydos et al., 2008). Adolescents that failed to follow the 
retesting protocol resulted reinfected during the follow up treatment.  
The CDC (2010) guidelines for STD treatment established that women or men 
should be retested approximately 3 months, 6 months, 9 months, and 1 year after 
treatment to avoid the elevated risks for PID in women and other complications in men 
and women. Failure to follow the appropriate treatment and to develop behavioral 




Research Question 2 
The results of this study demonstrated that there is a statistically significant 
association between reinfected adolescents whose sexual partners’ did not receive 
treatment, showing that the OR=1.713, 95%, CI 0.761-2.024, and p-value 0.029.Thus, 
this hypothesis was accepted. However, age (p-value 0.182) or gender (p-value 0.544) 
does not provide stastically significant differences. 
Adolescents are the most exposed group to Chlamydia trachomatis in United 
States (Porco et al., 2009). Post treatment infections occur because sexual partners have 
failed to be treated and have no notification for treatment. Chlamydia trachomatis 
reinfection in adolescents mostly occurs because even when they receive appropriate 
therapy and their sexual partners do not receive treatment (Batteiger et al., 2010; Hwang 
et al., 2005).  
There were 698 males (12.8%) and 4,573 females (87.2%) initially infected 
whose sexual partners received treatment. There were 571 males (16.6%) and 2,870 
females (83.4%) whose sexual partners did not receive treatment. Reinfected whose 
sexual partners received treatment were 10 males (7.9%) and 116 females (92.1%). 
Reinfected whose sexual partners did not receive treatment were 62 males (33.7%) and 
122 females (66.3%). This information is indicative that reinfection occurs when sexual 
partners of the reinfected adolescents haven’t been treated.  
The CDC (2010) guidelines for STD treatment established that sexual partners’ 
notification and treatment is necessary to reduce reinfection. This notification is the 




arrange the evaluation and treatment of the sexual partners. The direct health assistance 
should be accompanied by health counseling and appropriate services.  
Research Question 3 
The results of this study demonstrated that there is a statistically significant 
association between reinfected adolescents that did not participate in the sexual 
orientation program offered by the Department of Health. The logistic regression model 
presented that reinfected adolescents did not participate in the sexual orientation has an 
OR=1.243, 95% CI 0.762-2.026, p-value 0.034. Thus, this hypothesis was accepted. Age 
(p-value 0.0822) or gender (p-value 0.992) does not provide stastically significant 
differences. 
There were 648 males (12.8%) and 4,423 females (87.2%) initially infected that 
participated in the sexual orientation program. There were 566 males (15.4%) and 3,075 
females (84.6%) that did not participate in the sexual orientation program. Reinfected that 
participated in the sexual orientation program were 9 males (8.6%) and 96 females 
(91.4%). Reinfected that did not participate in the sexual orientation program were 56 
males (27.3%) and 149 females (72.7%).  
This is consistent with other researchers who showed that behavioral interventions 
integrating a change of behavior can significantly reduce unprotected sex, HIV and STI 
incidence (Patterson et al., 2008). Counseling and orientation are necessary to address the 
social and cultural conditions to identify barriers and solutions. According to DiClemente 
et al. (2007), familiar environment, parental monitoring, community, psychological 




adolescents and to help them to develop behavioral modifications toward sexuality. CDC 
(2010) guidelines for STD treatment emphasized and recommended that counseling about 
STDs is necessary to avoid recurrence. 
Regarding reinfection patterns based on age and gender, there is a statistically 
significant association between reinfected females with reinfection (OR=1.976, 95% CI 
1.605-2.334, p-value 0.009). Based on age, there is a statistically significant association 
between reinfected age group 18-19 and reinfection (OR=1.911, 95% CI 1.556-2.266, p-
value 0.006). 
 
Limitations of the Study 
This research was conducted using existing data that were gathered from the STD 
MIS system program of the Puerto Rico Department of Health. The information collected 
was from adolescents 15-19 of age that resulted with a positive Chlamydia trachomatis 
screening between January 2008 and December 2012. The study was limited to initial 
infection and reinfection. Follow up treatment, sexual partners’ treatment, and 
participation in the sexual orientation program were evaluated.  
I did not consider how much adolescents learned about chlamydia during the 
orientation program, or if the Department of Health made sure that during the orientation 
the adolescents understood what chlamydia is and how it is transmitted. Neither did I 
consider learning barriers toward treatment and prevention. I did not investigate if sexual 





Chlamydia trachomatis infections can cause serious morbidity and complications. 
I investigated some of the risks factors associated with chlamydia among Puerto Rican 
adolescents. Results showed that reinfection was associated with failure to follow the 
retesting protocol. Early detection and treatment are necessary to prevent health 
consequences. The CDC (2010) recommended sexual education since is the best way to 
avoid risky behavior and is cost effective. Preventive strategies can be based on CDC 
recommendations that emphasize the screening of all sexually active women age 25 or 
younger. This can be done as routine laboratory tests. Old women that present a risk 
factor for chlamydia infections, or that have a new or more sexual partner should also be 
screened. The use of condoms, consistently and correctly, can reduce the risk of 
chlamydia infections and its transmission.  
The principal goal of Chlamydia trachomatis prevention program is to control the 
silent epidemic and consequences of the sequelae. Because chlamydia infection is 
common in adolescents and young adults, its prevention requires the support of health 
care providers, health departments, and school personnel. School based programs about 
sexual orientation can emphasize the sexual abstinence or to be in a monogamous 
relationship with a partner that is uninfected. Chlamydia can be diagnosed and treated 
easily because suitable laboratory tests exist for rapid screening and treatment. 
According to the CDC (2010), repeat infections cause elevated risks of 
coinfections and other complications. Infected patients should be treated as well retested 




The screening is a critical component of the prevention program, because Chlamydia 
trachomatis infected persons are often asymptomatic. Health care providers as well the 
Department of Health should ensure the notification, evaluation, and treatment of sexual 
partners. The partners’ referral is an important form to evaluate sexual exposure as well 
to encourage them to participate in the examination and treatment. The lack of 
responsibility of treating sexual partners remains the major problem for reinfection (CDC 
2010). This is a particular problem for controlling Chlamydia trachomatis since reaching 
sexual partners and treating them prophylactically can eliminate the asymptomatic 
infection. Based on the results of this investigation, reinfection was associated with 
failure of sexual partners to receive treatment.  
The screening of STIs, sexual education programs and partners referral require 
attention to minimize chlamydia transmission and sequelae. Interventions for sexual 
orientation and behavioral changes can promote the use of contraception and decreasing 
the number of sexual partners as well knowing the implications of having a STD. Schools 
programs may target adolescent population toward chlamydia and other STDs 
transmission and consequences.  
Implications for Positive Social Change 
Results showed the prevalence of reinfection of Chlamydia trachomatis in young 
Puerto Rican adolescents; reinfection occurs due to failure to follow the retesting protocol 
of the department of health, sexual partners are not informed nor treated, and there is a 
poor participation in the sexual orientation program. The data showed that women are 




Results showed the need of a social positive change. It is important to talk with 
adolescents about chlamydia. It is important to promote a social approach to emphasize 
transmission, treatment, and sequelae. The awareness of this STD could reduce the 
impact of its transmission. I aimed to encourage healthy people. Early detection of 
chlamydia helps to protect people to develop other risk factors including coinfection with 
other diseases such HIV. 
Conclusion 
Chlamydia is the most common bacteria diagnosed worldwide. Its diagnosis rate 
is increasing yearly. Since this STD is mainly asymptomatic, screening, and treatment are 
necessary to detect and to reduce its transmission. I investigated reinfection among 
Puerto Rican adolescents between 2008-2012. Results were used to answer the research 
questions that established that failure to follow the retesting protocol, sexual partners’ 
failure to be treated and no participation in the sexual orientation program were 
associated with reinfection. Chlamydia screening programs are necessary to control its 
transmission.  
The CDC guidelines (2010) recommended the screening of all sexually active 
women age 25 or younger when visiting the gynecologist. High risk population, such as 
adolescents can be reached at school. This is an area needing further research. Schools 
may support this initiative, if it results cost effective. School based programs could be of 
STD counseling, education and behavioral interventions. Chlamydia is a preventable 
disease so with its management a reduction can be done. Education, counseling, and 
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